Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation

Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation

IntroductionComplement system has a postulated role in endothelial problems after hematopoietic stem cell transplantation (HSCT). In this retrospective, singlecenter study we studied genetic complement system variants in patients with documented endotheliopathy. In our previous study among pediatric...

Full description

Bibliographic Details
Main Authors:	Lilli Leimi, Jessica R. Koski, Outi Kilpivaara, Kim Vettenranta, A. Inkeri Lokki, Seppo Meri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Immunology
Subjects:	hematopoietic stem cell transplantation hematopoietic stem cell transplantation adverse effects acute toxicity vascular complications complement system endothelial damage
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1249958/full

Similar Items

Complement activation and vascular complications after pediatric allogeneic hematopoietic stem cell transplantation
by: Lilli Leimi, et al.
Published: (2025-02-01)

P1263: SINGLE NUCLEOTIDE POLYMORPHISMS IN PATIENTS WITH ENDOTHELIAL DAMAGE AFTER PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Lilli Leimi, et al.
Published: (2023-08-01)

A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
by: Qixiang Ye, et al.
Published: (2018-05-01)

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
by: Gianluigi Ardissino, et al.
Published: (2022-07-01)

Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
by: Zhao Jin, et al.
Published: (2024-05-01)

How Allogeneic Hematopoietic Stem Cell Transplantation has Evolved Over Time: 30-Years’ Experience at a Single Institution
by: Manuel Abecasis, et al.
Published: (2020-02-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Amir Ali Hamidieh, et al.
Published: (2009-01-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
by: Emmanuel Katsanis, et al.
Published: (2022-01-01)

Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
by: Jing Ma, et al.
Published: (2025-03-01)

Factors associated with the number of CD34-positive hematopoietic progenitor cells in the leukocyte concentrate in patients with lymphomas and acute T-lymphoblastic leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)

Toxoplasma gondii infection in children after allogeneic hematopoietic stem cell transplantation: A case report and literature review
by: Lijuan Luo, et al.
Published: (2021-09-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation
by: Yan Man, et al.
Published: (2021-01-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Hematopoietic stem cell transplantation: clinical use and perspectives
by: Francisco Barriga, et al.
Published: (2012-01-01)

Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation
by: Panpan Zhu, et al.
Published: (2024-03-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation
by: Davod Pashoutan Sarvar, et al.
Published: (2022-05-01)

Evaluation of efficacy and safety in the use of cytarabine for mobilization of hematopoietic stem cells in a reference hospital in northeastern Brazil
by: Kaio José Santos de Andrade, et al.
Published: (2024-10-01)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
by: Gaganvir Parmar, et al.
Published: (2023-03-01)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
by: Eleni Gavriilaki, et al.
Published: (2021-12-01)

Benefits of serum protein electrophoresis as part of hematopoietic stem cell donor clearance
by: Laura Kilinc, et al.
Published: (2024-10-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects
by: O. B. Ovsyannikova, et al.
Published: (2020-11-01)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
by: Michael M. B. Green, et al.
Published: (2016-08-01)

Hematopoietic Recovery after Transplantation CD117+B220- (lacZ+) Bone Marrow Cells in Lethally Irradiated Mice
by: Miroslav Hodek, et al.
Published: (2008-01-01)

An Overview of Autophagy in Hematopoietic Stem Cell Transplantation
by: Soheila Montazersaheb, et al.
Published: (2022-05-01)

Rhodococcus hoagii bloodstream infection in an allogeneic hematopoietic stem cell transplantation patient: Case report and review of literature
by: Pedro da Silva Campana, et al.
Published: (2020-01-01)

Transfusion support in the first 100 days of allogeneic, matched, related hematopoietic stem cell transplant
by: Prashant Pandey, et al.
Published: (2023-01-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
by: Mohammad Faizan Zahid, et al.
Published: (2014-12-01)

Exploring hematopoietic stem cell awareness and engagement among healthcare professionals: A cross-sectional survey
by: Vikash Chandra Mishra, et al.
Published: (2024-12-01)

Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontiﬁcia Universidad Católica de Chile
by: Pablo Ramirez, et al.
Published: (2015-06-01)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
by: Yue Lu, et al.
Published: (2023-01-01)